Literature DB >> 8741992

Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands.

S Liu1, D S Edwards, R J Looby, A R Harris, M J Poirier, J A Barrett, S J Heminway, T R Carroll.   

Abstract

A series of 99mTc complexes containing a hydrazinonicotinamide-conjugated cyclic IIb/IIIa receptor antagonist, cyclo(D-Val-NMeArg-Gly-Asp-Mamb-(hydrazinonicotinyl-5- (6-aminocaproic acid))), were synthesized in high yield using tricine or other aminocarboxylates as coligands. These 99mTc complexes have the potential to be used as thrombus imaging agents. The radiolabeling of the HYNIC-conjugated cyclic IIb/IIIa peptide (HYNICtide) was carried out by reaction with pertechnetate in the presence of excess tricine and stannous chloride at pH 4-5. The reaction time and temperature depend on the amount of the HYNICtide and pertechnetate used for the radiolabeling. Very high specific activity (> or = 20,000 mCi/mumol) can be achieved for the complex [99mTc(HYNICtide)(tricine)2] without postlabeling purification. The complex [99mTc(HYNICtide)(tricine)2] was found by two reversed phase HPLC methods to exist as multiple species, some of which interconvert, depending on the temperature, reaction time, and pH of the reaction mixture. The presence of these multiple species is most likely due to different bonding modalities of either the hydrazine moiety of the HYNICtide or the two tricine coligands. The complex [99mTc(HYNICtide)(EDDA)] (EDDA = ethylenediamine-N,N'-diacetic acid) was prepared either by reacting the cyclic IIb/IIIa HYNICtide with pertechnetate, excess EDDA, and stannous chloride at pH 4-5 and 75 degrees C for 30 min or by reacting excess EDDA with [99mTc(HYNICtide)(tricine)2]. The complex [99mTc(HYNICtide)(EDDA)] was found to be stable for at least 12 h in the reaction mixture. Three major species were detected in the radio-HPLC chromatograms, presumably due to the more limited number of possible coordination isomers. Similar results were obtained using other polydentate aminocarboxylates (such as HEDTA, N-(2-hydroxyethyl)ethylenediaminetriacetic acid) as coligands. It is clear that the replacement of tricine by other polydentate aminocarboxylates produces 99mTc-HYNICtide complexes with higher stability and fewer coordination isomers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741992     DOI: 10.1021/bc950069+

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  15 in total

1.  Syntheses and structural characterization of rhenium-bis-hydrazinopyrimidine core complexes with thiolate and Schiff base coligands.

Authors:  Frank J Femia; Xiaoyuan Chen; Kevin P Maresca; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-12-15       Impact factor: 2.545

2.  A novel ternary ligand system useful for preparation of cationic (99m)Tc-diazenido complexes and (99m)Tc-labeling of small biomolecules.

Authors:  Young-Seung Kim; Zhengjie He; Wen-Yuan Hsieh; Shuang Liu
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

Review 3.  Labeling biomolecules with radiorhenium: a review of the bifunctional chelators.

Authors:  Guozheng Liu; Donald J Hnatowich
Journal:  Anticancer Agents Med Chem       Date:  2007-05       Impact factor: 2.505

Review 4.  Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.

Authors:  Shuang Liu
Journal:  Adv Drug Deliv Rev       Date:  2008-04-23       Impact factor: 15.470

5.  Design and evaluation of new Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptides for melanoma imaging.

Authors:  Haixun Guo; Fabio Gallazzi; Yubin Miao
Journal:  Mol Pharm       Date:  2013-03-01       Impact factor: 4.939

6.  Synthesis and crystal and molecular structure of a tetranuclear cluster based on the rhenium(III)-bisorganohydrazino core: [Re(HNNC(4)H(3)N(2))(NNC(4)H(3)N(2))(OCH(3))(2)](4).

Authors:  Frank J Femia; Xiaoyuan Chen; Kevin P Maresca; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-09-01       Impact factor: 2.545

7.  How do HYNIC-conjugated peptides bind technetium? Insights from LC-MS and stability studies.

Authors:  Robert C King; M Bashir-Uddin Surfraz; Stefano C G Biagini; Philip J Blower; Stephen J Mather
Journal:  Dalton Trans       Date:  2007-09-25       Impact factor: 4.390

8.  99mTc-Demotate 1: first data in tumour patients-results of a pilot/phase I study.

Authors:  Clemens Decristoforo; Theodosia Maina; Berthold Nock; Michael Gabriel; Paul Cordopatis; Roy Moncayo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-04       Impact factor: 9.236

9.  Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination.

Authors:  M F Giblin; N Wang; T J Hoffman; S S Jurisson; T P Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

10.  Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT.

Authors:  Yang Zhou; Sudipta Chakraborty; Shuang Liu
Journal:  Theranostics       Date:  2011-01-18       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.